Sirolimus Tablet
Product Images NDC 50268-718

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Sirolimus (NDC 50268-718). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Avpak, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label 1 (Label 2018 04 23 At 9.14.15 Am)

This is a description of a medication labeled NDC 50268-718-13 with the name Sirolimus. It comes in tablet form, with a strength of 1mg and intended for oral use only. The pack contains 30 tablets, divided into three unit-dose packs. The medication is prescription-only, and the pharmacist must dispense the drug guide to each patient. It should be stored at a temperature of 20° to 25°C (68° 1o 77°F). The drug should be dispensed in tight, light-resistant, and child-resistant containers. Finally, the drug is manufactured by AKARE, Inc. in Pulaski, TN 38478.*

FDA Label Image

Structure (Structure)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.